Your browser doesn't support javascript.
loading
Cardiometabolic Risk Factors in Mexican Adults With Congenital Heart Disease.
García-Cruz, Edgar; Manzur-Sandoval, Daniel; Gopar-Nieto, Rodrigo; Plata-Corona, Juan C; Montalvo-Ocotoxtle, Isis G; Navarro-Martinez, Daniel Alejandro; Mier Y Terán-Morales, Elisa; Rivera-Buendía, Frida; Antonio-Villa, Neftali Eduardo; García-González, Naybeth E; Angulo-Cruzado, Stephanie T; Sánchez-López, Sheila V; Torres-Martel, José M; Díaz-Gallardo, Linda G; Barrera-Real, Axel J; Quiroz-Martínez, Víctor A; Pedroza, Montserrat Villalobos; Sánchez-Nieto, Jorge; Valdez-Ramos, Miriam; Ávila-Vanzzini, Nydia; Vera-Zertuche, Juan M; Baranda-Tovar, Francisco M.
Afiliação
  • García-Cruz E; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Manzur-Sandoval D; Cardiovascular Critical Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Gopar-Nieto R; Coronary Care Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Plata-Corona JC; Cardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Montalvo-Ocotoxtle IG; Endocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Navarro-Martinez DA; Department of Cardiothoracic and Vascular Surgery, University of Texas Health Science Center, Houston, Texas, USA.
  • Mier Y Terán-Morales E; Endocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Rivera-Buendía F; Research Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Antonio-Villa NE; Endocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • García-González NE; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Angulo-Cruzado ST; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Sánchez-López SV; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Torres-Martel JM; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Díaz-Gallardo LG; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Barrera-Real AJ; Endocrinology Department, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Quiroz-Martínez VA; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Pedroza MV; Cardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Sánchez-Nieto J; Cardiology Fellowship, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Valdez-Ramos M; Congenital Heart Disease Unit, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Ávila-Vanzzini N; General Cardiology Outpatient Clinic, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
  • Vera-Zertuche JM; Endocrinology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
  • Baranda-Tovar FM; Surgical and Medical Specialties Direction, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
JACC Adv ; 2(8): 100596, 2023 Oct.
Article em En | MEDLINE | ID: mdl-38938341
ABSTRACT

Background:

In recent decades, adults living with congenital heart disease (ACHD) have improved their survival, thus increasing their predisposition to the onset of cardiometabolic risk factors and chronic health conditions.

Objectives:

The purpose of this study was to describe cardiometabolic risk profiles in the ACHD population and their relationship to congenital heart disease (CHD) lesion complexity.

Methods:

We performed a cross-sectional study from ACHD in a third-tier referral center in Mexico City. The association between cardiometabolic risk factors and CHD complexity was estimated using logistic regression models.

Results:

Our study cohort included 1,171 ACHD patients (median age 31 [IQR 23.2-42.7] years, male 63.6%). Cardiac diagnosis was classified as mild (44.9%), moderate (37.8%), and severe (17.2%) CHD complexity. Low high-density lipoprotein cholesterol (55%) was the most common cardiometabolic risk factor; followed by insulin resistance (54.5%) and prediabetes (52.4%). Patients with mild and moderate CHD had a higher prevalence of obesity and metabolic syndrome, while patients with severe CHD had a higher prevalence of hyperuricemia and subclinical hypothyroidism. In the logistic regression analysis, the severity of CHD was associated with higher odds of hyperuricemia (moderate CHD, OR 1.87; 95% CI 1.20-2.93; P = 0.010; severe CHD, OR 2.75; 95% CI 1.64-4.62; P < 0.001) and lower risks of metabolic syndrome (OR 0.61; 95% CI 0.41-0.91; P = 0.010), prediabetes (OR 0.58; 95% CI 0.42-0.81; P < 0.001), and arterial hypertension (OR 0.49; 95% CI 0.33-0.74; P < 0.001) compared with mild CHD complexity.

Conclusions:

We observed high rates of cardiometabolic risk factors in Mexican ACHD patients and these risk profiles varied by CHD lesion complexity. These results highlight the need for ongoing metabolic health surveillance in the ACHD population.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2023 Tipo de documento: Article